| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.135 | 3.620 | 13.829 | 9.717 | 13.559 | 9.176 | 9.558 | 12.624 |
| Total Income - EUR | - | - | 1.135 | 3.620 | 13.829 | 9.717 | 13.559 | 9.176 | 9.558 | 12.624 |
| Total Expenses - EUR | - | - | 2.322 | 13.044 | 10.837 | 10.368 | 11.303 | 9.232 | 3.082 | 9.516 |
| Gross Profit/Loss - EUR | - | - | -1.186 | -9.424 | 2.992 | -651 | 2.256 | -56 | 6.476 | 3.108 |
| Net Profit/Loss - EUR | - | - | -1.220 | -9.568 | 2.577 | -943 | 2.050 | -332 | 6.476 | 2.596 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Sano Teraphy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 712 | 699 | 685 | 672 | 657 | 659 | 0 | 0 |
| Current Assets | - | - | 202 | 1.796 | 3.297 | 5.491 | 10.869 | 8.676 | 8.840 | 5.326 |
| Inventories | - | - | 0 | 1.610 | 2.186 | 2.469 | 2.365 | 1.862 | 2.394 | 1.693 |
| Receivables | - | - | 0 | 0 | 0 | 2.115 | 8.313 | 6.686 | 0 | 0 |
| Cash | - | - | 202 | 186 | 1.111 | 908 | 191 | 128 | 6.446 | 3.633 |
| Shareholders Funds | - | - | -1.177 | -10.724 | -7.938 | -8.731 | -6.487 | -6.839 | -342 | 2.256 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 2.091 | 13.218 | 11.920 | 14.894 | 18.013 | 16.174 | 9.182 | 3.070 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Sano Teraphy S.r.l.